1.http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm427913.htm (Accessed on January 05, 2015).
2. 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial. Lancet 2017